The most useful habit for RRT-level review is problem-first classification: before choosing any answer about ventilator settings, drugs, or weaning, name the physiologic problem — oxygenation or ventilation, resistance or compliance, shunt or deadspace. This guide teaches that classification through two worked ventilator scenarios, a drug-selection comparison, weaning logic, and a weekly drill with a scoring rubric. Work each scenario on paper, commit to a choice, then read the reasoning and the mistake each one is built to expose.
Label the Physiologic Problem Before Choosing Any Ventilator Change
Every mechanical ventilation decision traces to one of two axes: oxygenation, reflected in PaO2 and influenced by FiO2, PEEP, and mean airway pressure; and ventilation, reflected in PaCO2 and governed by alveolar ventilation.
The two axes are independent, and that independence is the whole game. Alveolar ventilation equals (tidal volume minus deadspace) multiplied by respiratory rate, and PaCO2 varies inversely with it — so rate and tidal volume are the levers for carbon dioxide, assuming metabolic CO2 production is stable. Oxygenation, by contrast, responds mainly to FiO2, PEEP, and mean airway pressure. FiO2 enriches inspired gas; it does nothing to remove CO2 from the body.
Confusing the axes produces answers that sound active but miss the target. Raising FiO2 will not correct a high PaCO2, because oxygen enrichment changes neither alveolar ventilation nor deadspace. Raising PEEP can improve PaO2 through recruitment while simultaneously increasing deadspace and reducing venous return, which can worsen both CO2 elimination and blood pressure. A practical discipline for every practice item: write one line before answering — problem, axis, target parameter. The table below shows the pattern applied to the five most common case shapes.
Administrative details such as eligibility, scheduling, and the current examination structure belong to the credentialing body — verify them at nbrc.org rather than relying on older outlines.
| Finding on ABG or ventilator | Physiologic problem | Matched first adjustment | Change to avoid and why |
|---|---|---|---|
| Low PaO2 that rises when FiO2 is added | V/Q mismatch | Increase FiO2 | Raising Vt or rate — PaCO2 is normal, so ventilation is not the problem |
| Low PaO2 that stays low despite high FiO2 | Shunt (perfused but unventilated alveoli) | Recruitment: raise PEEP within protocol limits | Chasing it with FiO2 alone — shunted blood never contacts ventilated alveoli |
| High PaCO2 with low total minute ventilation | Alveolar hypoventilation | Increase set rate or Vt after checking plateau pressure | Adding PEEP — it targets oxygenation, not CO2 elimination |
| High PaCO2 despite seemingly adequate minute ventilation | Elevated deadspace | Verify plateau safety, then raise rate to increase effective alveolar ventilation | Raising Vt blindly — plateau pressure may already be near the safety limit |
| Peak pressure far above plateau pressure | High airway resistance | Suction, bronchodilation, shorter inspiratory time | Diagnosing low compliance — the gradient points to resistance, not stiff lungs |
Worked Scenario: Hypercapnia in Volume Control — Rate, Vt, or PEEP?
This scenario shows pure ventilatory failure with adequate oxygenation, so the correct move is raising alveolar ventilation after a plateau check — and the plausible mistake is reaching for PEEP or FiO2 instead.
The case: an adult with ideal body weight of about 70 kg on assist-control volume control, Vt 420 mL (6 mL/kg IBW), set rate 14, so minute ventilation is roughly 5.9 L/min. The ABG reads pH 7.27, PaCO2 62, PaO2 94 on FiO2 0.45. The tempting choice is to raise PEEP to 10 and push FiO2 to 0.6 because the patient 'looks sick.' That choice treats a PaO2 of 94 — a number that is already acceptable — and leaves the actual abnormality, the PaCO2 of 62, untouched. Worse, added PEEP tends to increase deadspace, which can push PaCO2 higher still.
The better decision starts with a plateau pressure check. At a plateau of 24 cm H2O, there is room under the usual safety limit, so alveolar ventilation can be raised by increasing Vt toward 7 mL/kg (about 490 mL) or by raising the rate — in this simplified scenario PaCO2 falls roughly in proportion to the increase in alveolar ventilation. If you raise the rate instead of Vt in a patient at risk for air trapping, watch exhalation time and auto-PEEP on the follow-up tracing. The reason this matters: the two levers act on different axes, and choosing by diagnosis label instead of by the ABG pattern is exactly the reasoning error this credential is meant to distinguish.
Worked Scenario: Peak 48, Plateau 20 — Resistance, Not Stiffness
A wide peak-to-plateau gradient with a normal plateau identifies high airway resistance, so the plan is airway clearance, bronchodilation, and more exhalation time — not a diagnosis of stiff lungs that calls for more PEEP.
The case: a COPD exacerbation on volume control. Peak inspiratory pressure is 48 cm H2O, plateau pressure is 20 cm H2O, and the expiratory flow trace never returns to zero before the next breath; blood pressure is trending down. The plausible mistake is reading 'high pressure' as low compliance, invoking a stiff-lungs picture, and responding by raising PEEP and cutting Vt. The pressure breakdown says otherwise: peak pressure includes airway resistance plus alveolar pressure, while plateau reflects compliance alone. A peak-plateau gradient of about 28 cm H2O with a plateau of 20 is a resistance problem — secretions, bronchospasm, or a kinked or obstructed tube — combined with gas trapping.
The better sequence follows from the label: suction and deliver a bronchodilator, increase inspiratory flow to shorten inspiratory time and lengthen the exhalation window, and measure auto-PEEP from an expiratory hold. If the patient struggles to trigger because trapped gas imposes intrinsic PEEP, a common textbook approach is setting extrinsic PEEP below the measured auto-PEEP (often around 80 percent) and monitoring the response. In a paper scenario of severe hemodynamic compromise from air trapping, the protocol-based expected action is temporary circuit disconnection to release trapped gas, done on an order with monitoring. This is the opposite PEEP logic from a stiff-lungs case — which is precisely why the classification must come first.
Matching Drug Classes to the Goal, Not to the Diagnosis Label
Drug items are decided at the receptor and onset level: beta-agonists and anticholinergics relax bronchial smooth muscle, corticosteroids suppress inflammation over hours, and none of them mobilizes secretions — each goal selects its own class.
Compare the two cornerstone inhaled bronchodilators at the receptor level. Albuterol is a beta-2 agonist: it relaxes bronchial smooth muscle quickly through cyclic AMP signaling, making it the agent for acute bronchospasm. Ipratropium is an anticholinergic: it blocks muscarinic-mediated bronchoconstriction and vagal tone, with a slower peak, and is commonly paired with a beta-agonist because the mechanisms are complementary rather than redundant. Delivery choice is also a decision point: a metered-dose inhaler with a spacer versus a small-volume nebulizer depends on the patient's coordination, the setting, and whether the patient is ventilated — not on the drug itself.
The timing distinction trips up plausible wrong answers. Corticosteroids — inhaled or systemic — reduce airway inflammation and are central to managing reactive airway disease over hours to days, but they are not immediate bronchodilators; in an item about sudden, severe bronchospasm, the class that matches the acute goal is the fast-acting beta-agonist, with steroids as the background therapy. Similarly, a mucolytic addresses thick secretions and does nothing for smooth-muscle spasm, while a bronchodilator does nothing to thin mucus. Read the item for its stated goal — relieve now, reduce inflammation, or clear secretions — and let the goal, not the disease name, pick the class.
Shunt, Deadspace, and V/Q Mismatch: Three Patterns, Three Responses
V/Q mismatch responds to supplemental oxygen, shunt does not, and deadspace raises PaCO2 while widening the PaCO2-to-EtCO2 gradient — each pattern has a signature and a different first response.
Define the three patterns directionally. Shunt means perfusion without ventilation: blood passes through unventilated alveoli — consolidation, atelectasis, edema — and leaves the lungs without ever contacting alveolar gas, which is why added oxygen barely moves PaO2; this is refractory hypoxemia. V/Q mismatch means both ventilation and perfusion exist but are unevenly matched, so enriched inspired gas reaches most of the perfused blood and PaO2 responds to FiO2. Deadspace is the inverse of shunt: ventilation without perfusion, typically showing a high PaCO2 or a widening gap between arterial and end-tidal CO2.
Apply the signatures to item cues. If a case shows severe hypoxemia that persists despite high FiO2, the data are pointing at shunt, and the reasoning that follows is recruitment and PEEP management rather than oxygen escalation. If a case shows rising PaCO2 with a large arterial-to-end-tidal CO2 gradient, the data point at deadspace — think pulmonary embolism or overdistension from excessive PEEP — and the response is reassessment of ventilatory strategy. The mistake to avoid is treating refractory hypoxemia with FiO2 escalation alone, which implies blood that extra oxygen could theoretically reach. Drill with three-line cases: ABG, one response-to-oxygen clue, one waveform clue, then classify before deciding.
Weaning Items: A Screening Threshold Is Not a Readiness Trial
Weaning questions distinguish a screening measurement, such as the rapid shallow breathing index, from evidence of readiness, such as a tolerated spontaneous breathing trial — a number qualifies a patient for the trial rather than ending the decision.
Know the named measures and their roles. The rapid shallow breathing index (RSBI) is respiratory frequency divided by tidal volume in liters; a low value (a common textbook screen is under about 100 breaths/min/L) suggests breathing mechanics that will not immediately fatigue. Negative inspiratory force and spontaneous tidal volume fill the same screening role. All of these are measures of mechanics taken on minimal support — they tell you a patient is worth testing, which is a conditional statement, not a verdict on readiness.
The plausible mistake is treating a favorable RSBI as the finish line while ignoring what trials actually test: sedation level and mental status, secretion burden, the reason ventilation started, and how the patient sustains effort over minutes. The better sequence is screen, then spontaneous breathing trial with observation of rate, effort, gas exchange, and hemodynamics, then a cause-focused reassessment if the trial fails. A failed trial is data — it points to the physiologic or non-respiratory factor still blocking liberation, such as residual sedation or fluid overload, and the answer that follows names that factor rather than repeating the screen.
A Weekly Drill Cycle With a Rubric and Concrete Readiness Checks
Build review around a repeating cycle: classify paper cases, score yourself against a five-point rubric, track which problem types you mislabel, and re-drill those types until classification is immediate.
The exercise: each week, write or collect ten paper cases — some ABG-only, some waveform-description-only, some combining both. For each case, write five things before checking any reference: the named physiologic problem, the axis it acts on, the single target parameter, the safety check that must precede the change, and one rejected alternative with a physiologic reason. Then score yourself on the rubric below. Expected observations: early scores below 3 out of 5 are normal and useful; classification time should shrink over repeated cycles; and mislabels tend to cluster at the two boundaries — shunt versus V/Q mismatch, and resistance versus compliance — so those boundaries deserve the extra repetitions.
An adaptable sequence: weeks one and two, patient assessment and ABG classification drills; weeks three and four, ventilator mechanics and waveform interpretation using the two scenarios above as templates; week five, pharmacology matching by goal; week six, pathophysiology mapped onto the shunt-deadspace-V/Q patterns; week seven, critical care and weaning logic; week eight, mixed timed drills drawn from all areas. Readiness checks before you call review complete: you can state the axis of any ABG in seconds, compute IBW-based Vt, minute ventilation, P/F ratio, and RSBI correctly, and explain in one sentence why raising FiO2 never fixes hypercapnia and why a corticosteroid is not a rescue agent.
- Named the physiologic problem in one phrase (1 point)
- Chose the parameter that acts on the correct axis (1 point)
- Stated the safety check — plateau pressure, exhalation time, or monitoring — before adjusting (1 point)
- Rejected at least one alternative with a physiologic reason (1 point)
- Computed IBW, tidal volume, minute ventilation, or RSBI correctly where the case requires it (1 point)
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.